...
首页> 外文期刊>Cardiovascular and Interventional Radiology: A Journal of Imaging in Diagnosis and Treatment >Management of postoperative lymphoceles after lymphadenectomy: Percutaneous catheter drainage with and without povidone-iodine sclerotherapy
【24h】

Management of postoperative lymphoceles after lymphadenectomy: Percutaneous catheter drainage with and without povidone-iodine sclerotherapy

机译:淋巴结清扫术后的淋巴结肿大的处理:有无聚乙烯吡咯烷酮-碘硬化疗法的经皮导管引流

获取原文
获取原文并翻译 | 示例

摘要

Purpose: To report our single-center experience in managing symptomatic lymphoceles after lymphadenectomy for genitourinary and gynecologic malignancy and to compare clinical outcomes of percutaneous catheter drainage (PCD) alone versus PCD with transcatheter povidone-iodine sclerotherapy (TPIS). Methods: The medical records of patients who presented for percutaneous drainage of pelvic lymphoceles from February 1999 to September 2007 were retrospectively reviewed. Catheters with prolonged outputs >50 cc/day were treated with TPIS. Technical success was defined as the ability to achieve complete resolution of the lymphocele. Clinical success was defined as resolution of the patient's symptoms that prompted the intervention. Results: Sixty-four patients with 70 pelvic lymphoceles were treated. Forty-six patients (71.9 %) had PCD, and 18 patients (28.1 %) had multisession TPIS. The mean initial cavity size was 294.9 cc for those treated with TPIS and 228.2 cc for those treated with PCD alone (range 15-1,600) (p = 0.59). Mean duration of catheter drainage was 19 days (29 days with TPIS, 16 days with PCD, p = 0.001). Mean clinical follow-up was 22.6 months. Technical success was 74.3 % with PCD and 100 % with TPIS. Clinical success was 97 % with PCD and 100 % with TPIS. Postprocedural complications included pericatheter fluid leakage (n = 4), catheter dislodgement (n = 3), catheter occlusion (n = 9), and secondary infection of the collection (n = 4). Conclusion: PCD of symptomatic lymphoceles is an effective postoperative management technique. Initial cavity size is not an accurate predictor of the need for TPIS. When indicated, TPIS is safe and effective with catheter outputs >50 cc/day.
机译:目的:报告我们在处理泌尿生殖系统和妇科恶性肿瘤淋巴结清扫术后症状性淋巴囊肿的单中心经验,并比较单独经皮导管引流术(PCD)与经导管经聚维酮碘硬化疗法(TPIS)的PCD的临床结果。方法:回顾性分析1999年2月至2007年9月行经皮盆腔盆腔淋巴引流术的患者的病历。 TPIS处理了长期输出> 50 cc / day的导管。技术上的成功定义为达到完全解决淋巴膨出的能力。临床成功定义为促使患者干预的症状缓解。结果:收治64例70例盆腔淋巴结肿大患者。 46例(71.9%)患有PCD,18例(28.1%)患有多疗程TPIS。 TPIS治疗的平均初始腔体大小为294.9 cc,单独PCD治疗的平均初始腔体大小为228.2 cc(范围15-1,600)(p = 0.59)。导管引流的平均持续时间为19天(TPIS为29天,PCD为16天,p = 0.001)。平均临床随访时间为22.6个月。 PCD技术成功率为74.3%,TPIS技术成功率为100%。 PCD的临床成功率为97%,TPIS的临床成功率为100%。手术后并发症包括导管漏液(n = 4),导管移位(n = 3),导管阻塞(n = 9)和继发感染(n = 4)。结论:有症状淋巴囊肿的PCD是一种有效的术后处理技术。初始腔体尺寸不能准确预测TPIS的需求。指示时,TPIS安全有效,导管输出> 50 cc / day。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号